<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: gabitril</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'gabitril'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22gabitril%22&t=%22gabitril%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 03:02:20 +0100</lastBuildDate>
        <item>
            <title>Popular Anticonvulsants Raise Suicide Risks: Study</title>
            <link>http://www.medworm.com/index.php?rid=3468020&amp;cid=t_204576_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FX2JmApk8MdI%2F</link>
            <description>Several widely used anticonvulsants, including Pfizer&amp;#8217;s Neurontin, may increase the risk of suicide, attempted suicide and violent death in patients taking them for the first time, according to a study in the Journal of the American Medical Association.
Compared with Johnson &amp;#038; Johnson&amp;#8217;s Topamax (known generically as topiramate), the study found increased suicide risks for new patients using Neurontin (sold generically as gabapentin); GlaxoSmithKline&amp;#8217;s Lamictal; Novartis&amp;#8217; Trileptal, or Cephalon&amp;#8217;s Gabitril. Researchers also found an increased risk with Abbott Labs&amp;#8217; Depakine and Epilim, which is sold by Sanofi-Aventis.
The findings come two years after the FDA required anticonvulsants to carry a warning they double the risk of suicidal thoughts and beh...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3468020</comments>
            <pubDate>Wed, 14 Apr 2010 12:04:48 +0100</pubDate>
            <guid isPermaLink="false">3468020</guid>        </item>
        <item>
            <title>Abstract: Effects of the GABA-reuptake inhibitor Tiagabine on panic and anxiety in patients with panic disorder</title>
            <link>http://www.medworm.com/index.php?rid=3012449&amp;cid=t_204576_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_effects_of_the_gabareuptake_inhibitor_tiagabine_o.htm</link>
            <description>Discussion: Whereas tiagabine did not show beneficial effects on clinical symptoms in PD compared to placebo, results of challenge experiments suggest effects of TGB on sensitivity to experimentally induced panic. Source... &amp;copy; Georg Thieme Verlag KG Stuttgart &amp;nbsp; New York (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3012449</comments>
            <pubDate>Fri, 20 Nov 2009 06:33:00 +0100</pubDate>
            <guid isPermaLink="false">3012449</guid>        </item>
        <item>
            <title>Gabitril Goes Down</title>
            <link>http://www.medworm.com/index.php?rid=1841010&amp;cid=t_204576_109_f&amp;fid=34800&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F407457566%2Fgabitril-goes-down.html</link>
            <description>Gabitril (tiagabine) is an antiseizure medication from Cephalon, which just forked out a cool $425 million to settle charges that it marketed several drugs for unapproved conditions, including Provigil and Gabitril. Government investigators claimed that Gabitril was marketed as a treatment for anxiety, which is too bad considering that it struck out in three clinical trials against a placebo. Each study found no evidence that Gabitril was better than a sugar pill. Gabitril was also allegedly marketed as a treatment for pain. I was unable to locate a single controlled study examining the efficacy of Gabitril for pain, though there were a small number of uncontrolled (i.e., not very useful) studies suggesting that maybe Gabitril could be used to treat pain. Regarding sleep, the placebo-contr...</description>
            <author>Clinical Psychology and Psychiatry: A Closer Look</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1841010</comments>
            <pubDate>Tue, 30 Sep 2008 17:14:00 +0100</pubDate>
            <guid isPermaLink="false">1841010</guid>        </item>
        <item>
            <title>Cephalon Pays $425 Million For Medicaid Fraud</title>
            <link>http://www.medworm.com/index.php?rid=1841253&amp;cid=t_204576_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F406366468%2F</link>
            <description>This looks to be the biggest such case involving a biotech. And this involves three - count &amp;#8216;em, three - drugs that were allegedly marketed for years on an off-label basis in order to greatly widen the potential patient populations, according to court documents. The Cephalon payment includes $375 million in a nationwide Medicaid fraud settlement and $50 million for a corporate criminal plea (here&amp;#8217;s the settlement agreement).
The drugs in question - Actiq, a &amp;#8220;medicated lozenge on a handle&amp;#8221; approved only for pain in cancer patients and later linked to some 100 deaths; the Gabitril epilepsy med for adults and children over 12 years, but was pitched as an alternative to Valium and Zanax, and for treating for depression; and Provigil, a narcolepsy med that was promoted f...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1841253</comments>
            <pubDate>Mon, 29 Sep 2008 15:43:39 +0100</pubDate>
            <guid isPermaLink="false">1841253</guid>        </item>
    </channel>
</rss>

